These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 9270575)

  • 41. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y; Miki M; Tabata T
    Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Armodafinil for excessive daytime sleepiness.
    Nishino S; Okuro M
    Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T; Rippon GA; Arora S
    Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modafinil: a double-blind multicentric study.
    Billiard M; Besset A; Montplaisir J; Laffont F; Goldenberg F; Weill JS; Lubin S
    Sleep; 1994 Dec; 17(8 Suppl):S107-12. PubMed ID: 7701191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study.
    Joo EY; Tae WS; Jung KY; Hong SB
    J Sleep Res; 2008 Mar; 17(1):82-8. PubMed ID: 18275558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.
    Adler CH; Caviness JN; Hentz JG; Lind M; Tiede J
    Mov Disord; 2003 Mar; 18(3):287-293. PubMed ID: 12621632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome.
    De Cock VC; Diene G; Molinas C; Masson VD; Kieffer I; Mimoun E; Tiberge M; Tauber M
    Am J Med Genet A; 2011 Jul; 155A(7):1552-7. PubMed ID: 21671379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Normalizing effects of modafinil on sleep in chronic cocaine users.
    Morgan PT; Pace-Schott E; Pittman B; Stickgold R; Malison RT
    Am J Psychiatry; 2010 Mar; 167(3):331-40. PubMed ID: 20080983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Armodafinil.
    Garnock-Jones KP; Dhillon S; Scott LJ
    CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
    Czeisler CA; Walsh JK; Roth T; Hughes RJ; Wright KP; Kingsbury L; Arora S; Schwartz JR; Niebler GE; Dinges DF;
    N Engl J Med; 2005 Aug; 353(5):476-86. PubMed ID: 16079371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.
    Ondo WG; Fayle R; Atassi F; Jankovic J
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1636-9. PubMed ID: 16291885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy.
    MacDonald JR; Hill JD; Tarnopolsky MA
    Neurology; 2002 Dec; 59(12):1876-80. PubMed ID: 12499477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial.
    Trotti LM; Blake T; Hoque R; Rye DB; Sharma S; Bliwise DL
    CNS Drugs; 2024 Nov; 38(11):909-920. PubMed ID: 39306601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modafinil for narcolepsy: systematic review and meta-analysis.
    Golicki D; Bala MM; Niewada M; Wierzbicka A
    Med Sci Monit; 2010 Aug; 16(8):RA177-86. PubMed ID: 20671626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.